Adrenergic alpha-Agonists - Therapeutic use
Research News and Information

Sunday, November 22, 2009

Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients.

16 Aug 2009 OBJECTIVE: To review the literature regarding the use of alpha(2)-agonists in the treatment and prevention of iatrogenic opioid abstinence syndrome (IOAS) in critically ill patients. DATA SOURCES: Primary literature was identified through a search ... Read more...

Clonidine in perioperative medicine and intensive care unit: more than an anti-hypertensive drug.

30 Jul 2009 Clonidine is classified as an imidazoline and it is the prototypical alpha-2 receptor agonists. It has been used for several years to treat hypertension. It has also been used, "off label", for a variety of purposes, including opioid and anesthetic ... Read more...

Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome.

30 Jul 2009 INTRODUCTION: Few therapeutic modalities exist for the treatment of hepatorenal syndrome (HRS). The combination of octreotide, midodrine, and albumin has shown possible benefit in small preliminary studies in improving renal function and short-term ... Read more...

Latest indexed articles for 'Adrenergic alpha-Agonists - Therapeutic use'

These are the very latest articles for this heading:

• The possible mechanism of clonidine to suppress fentanyl-induced coughing. 29 Sep 2009
• New caudal additives in children: benefit vs. risk? 30 Aug 2009
• Pulse contour analysis aids the understanding of autonomic dysreflexia: hemodynamic findings in a T5 paraplegic surgical patient treated for hypotension with phenylephrine and ephedrine. 20 Aug 2009
• Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. 16 Aug 2009
• Clonidine in perioperative medicine and intensive care unit: more than an anti-hypertensive drug. 30 Jul 2009
• Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome. 30 Jul 2009
• Opioid dependence treatment: options in pharmacotherapy. 30 Jul 2009
• Hypothermic responses to infection are inhibited by alpha2-adrenoceptor agonists with possible clinical implications. 21 Jul 2009
• [Severe differed respiratory depression after intrathecal administration of morphine and clonidine on a 70-year-old patient] 5 Jul 2009
• Use of clonidine in the prevention and management of neonatal abstinence syndrome. 29 Jun 2009
• Pharmacological analysis of alpha(2)-adrenoceptor subtypes mediating analgesic, anti-inflammatory and gastroprotective actions. 11 Jun 2009
• Preoperative clonidine or levobupivacaine--effect on systemic inflammatory stress response. 30 May 2009
• Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. 30 May 2009
• The efficacy of intrathecal morphine with or without clonidine for postoperative analgesia after radical prostatectomy. 30 May 2009
• Treating agitation with dexmedetomidine in the ICU. 29 Apr 2009
• Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. 25 Apr 2009
• Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis. 21 Apr 2009
• alpha-Adrenoceptor agonists for the treatment of vasovagal syncope: a meta-analysis of worldwide published data. 19 Apr 2009
• Using sympathomimetic drugs to manage hypotension 2: use in clinical practice. 19 Apr 2009
• Alpha2-adrenergic agonists for the management of opioid withdrawal. 13 Apr 2009

See a longer list of these articles.

Technical information about 'Adrenergic alpha-Agonists'

Definition: Drugs that selectively bind to and activate alpha adrenergic receptors.

Registry Number: 0

Descriptor UI: D000316

Alternative terms: Adrenergic alpha-Agonists; Adrenergic alpha Agonists; alpha-Agonists, Adrenergic; Receptor Agonists, Adrenergic alpha; Receptor Agonists, alpha-Adrenergic; Agonists, alpha-Adrenergic Receptor; Receptor Agonists, alpha Adrenergic; alpha-Adrenergic Receptor Agonist; Agonist, alpha-Adrenergic Receptor; Receptor Agonist, alpha-Adrenergic; alpha Adrenergic Receptor Agonist; alpha-Adrenergic Receptor Agonists; alpha Adrenergic Receptor Agonists; Adrenergic alpha-Agonist; Adrenergic alpha Agonist; alpha-Agonist, Adrenergic; alpha-Adrenergic Agonist; Agonist, alpha-Adrenergic; alpha Adrenergic Agonist; alpha-Adrenergic Agonists; Agonists, alpha-Adrenergic; alpha Adrenergic Agonists; Adrenergic alpha-Receptor Agonist; Adrenergic alpha Receptor Agonist; Agonist, Adrenergic alpha-Receptor; alpha-Receptor Agonist, Adrenergic; Adrenergic alpha-Receptor Agonists; Adrenergic alpha Receptor Agonists; Agonists, Adrenergic alpha-Receptor; alpha-Receptor Agonists, Adrenergic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.519.625.050.100.100; D27.505.696.577.050.100.100;

Online Note: use ADRENERGIC ALPHA-AGONISTS to search ADRENERGIC ALPHA RECEPTOR AGONISTS 1969-94 (as Prov 1969-72)

History Note: 95; was ADRENERGIC ALPHA RECEPTOR AGONISTS 1969-94 (Prov 1969-72)

Technical Notes: GEN or unspecified; prefer specifics; do not confuse with ADRENERGIC ALPHA-ANTAGONISTS; DF: ADREN ALPHA AGON or ADREN ALPHA AG